 DAVENPORT Co LLC decreased its holdings in Nektar Therapeutics NASDAQ:NKTR by 6.8 during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 58,300 shares of the biopharmaceutical companys stock after selling 4,250 shares during the period. DAVENPORT Co LLCs holdings in Nektar Therapeutics were ... 